Topic: Genetics and APOE
Plain-language summary
Psychosis is a neuropsychiatric feature found across neurodegenerative conditions including Alzheimer’s disease (AD) and Parkinson’s disease (PD). It is also a common feature in psychiatric disorders such as schizophrenia. The apolipoprotein E epsilon 4 (ApoE4) allele is an established genetic risk factor for AD that may also increase the risk of psychosis. However, evidence regarding the association between ApoE4 and psychosis remains unclear. This paper evaluates the relationship between "ApoE" 4 carrier status and psychosis in both neurodegenerative (Alzheimer’s disease and Parkinson’s disease) and non-neurodegenerative disorders (schizophrenia). Additionally it explores whether sex and zygosity modulate this association.A literature review of studies identified through PubMed and Scopus was conducted. Thirty- one studies, were included that investigated the relationship between ApoE4 and psychosis in select neurodegenerative and psychiatric populations. Studies were included if they assessed ApoE4 status in relation to the presence, severity, or age of onset of psychosis.Among the 16 AD- focused studies, a positive association was reported in 11 while 4 showed no significant association and one showed an inverse correlation. ApoE4 carriers and ApoE4 homozygotes that were female were reported to have the strongest association. The three studies examining PD resulted in inconsistent findings limited by small sample sizes. With respect to schizophrenia, associations were predominantly null or inconsistent. There was limited evidence for the influence of sex or ApoE4 zygosity.Of note the risk was enhanced in female carriers and "ApoE" 4 homozygotes. In terms of PD results were conflicting, limited by small sample sizes. Schizophrenia studies produced findings that were predominantly null or equivocal, with no clear evidence that sex or zygosity influenced outcomes.ApoE4 positivity appears to have a stronger association with psychosis in AD compared to PD or schizophrenia. Available evidence suggests that this relationship may be modified by sex and ApoE4 zygosity and that female ApoE4 homozygotes are particularly vulnerable. Findings were however limited by substantial heterogeneity across studies and limited evidence in PD and schizophrenia populations. Thus larger studies are needed to clarify the role of ApoE4 in psychosis, particularly in non-AD cohorts.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Wasef, V., Rashidi-Ranjbar, N., Churchill, N. W., Fornazzari, L., De Luca, V., Graham, S. J., et al. (2026). ApoE4 and Psychosis in Neurodegenerative and Non-Neurodegenerative Disease: A Scoping Review. Preprints.org. https://doi.org/10.20944/preprints202610.2617.v1
Vancouver
Wasef V, Rashidi-Ranjbar N, Churchill NW, Fornazzari L, De Luca V, Graham SJ, et al. ApoE4 and Psychosis in Neurodegenerative and Non-Neurodegenerative Disease: A Scoping Review. Preprints.org. 2026. doi:10.20944/preprints202610.2617.v1.
BibTeX
@article{wasef2026-1d706ebb,
author = {Wasef, V. and Rashidi-Ranjbar, N. and Churchill, N. W. and Fornazzari, L. and De Luca, V. and Graham, S. J. and Munoz, D. G. and Schweizer, T. A. and others},
title = {{ApoE4 and Psychosis in Neurodegenerative and Non-Neurodegenerative Disease: A Scoping Review}},
journal = {Preprints.org},
year = {2026},
doi = {10.20944/preprints202610.2617.v1},
url = {https://doi.org/10.20944/preprints202610.2617.v1}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Studies were included if they assessed ApoE4 status in relation to the presence, severity, or age of onset of psychosis.Among the 16 AD- focused studies, a positive association was reported in 11 while 4 showed no significant association and one showed an inverse correlation.
- In terms of PD results were conflicting, limited by small sample sizes.
- Schizophrenia studies produced findings that were predominantly null or equivocal, with no clear evidence that sex or zygosity influenced outcomes.ApoE4 positivity appears to have a stronger association with psychosis in AD compared to PD or schizophrenia.
- Available evidence suggests that this relationship may be modified by sex and ApoE4 zygosity and that female ApoE4 homozygotes are particularly vulnerable.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Evidence strengthLow
How this study scored 16/100
Preprint — not yet peer-reviewed. It scored 21 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 13 of the 62 points we could judge it on, which is 21 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 2 / 10 | Tier 4 — not a peer-reviewed journal (Preprints.org) |
| Journal's citation record | 0 / 4 | Not a journal article, so the journal's record does not count |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 4 / 10 | Preprint — not yet peer-reviewed. Hosted on a preprint server. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 13 / 62 | Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 13 of the 62 points we could judge it on is 21 out of 100. |
| Total | 21 / 100 | Capped to 16 because this is not a peer-reviewed article. |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Genetics from nearby years
Also tagged “apoe2”
265 studies in the library carry the topic tag “apoe2”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 265 tagged studies.